Related Experiment Videos

In vitro insulin-like actions of the growth factor from the tapeworm, Spirometra mansonoides

M A Salem1, C K Phares

  • 1Department of Biochemistry, University of Nebraska Medical Center, Omaha 68105.

Insights

Plerocercoid growth factor (PGF) exhibits direct insulin-like actions in rat adipose tissue by binding to growth hormone (GH) receptors. Unlike insulin, PGF

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Molecular Biology

Background:

  • Plerocercoid growth factor (PGF) is a protein with poorly understood biological functions.
  • Insulin and human growth hormone (hGH) play critical roles in regulating glucose and lipid metabolism.
  • Adipose tissue is a key metabolic organ responsive to hormonal signaling.

Purpose of the Study:

  • To compare the in vitro metabolic actions of PGF with insulin and hGH in rat adipose tissue.
  • To investigate the receptor binding characteristics of PGF in adipocytes.
  • To elucidate the mechanism of PGF's insulin-like effects.

Main Methods:

  • In vitro incubation of rat adipose tissue with PGF, insulin, and hGH.
  • Measurement of [U-14C]glucose oxidation to 14CO2.
  • Assessment of lipogenesis and inhibition of epinephrine-induced lipolysis.
  • Competitive binding assays using 125I-insulin and 125I-hGH.

Main Results:

  • PGF and insulin significantly stimulated glucose oxidation and lipogenesis in adipose tissue.
  • hGH showed insulin-like effects only after preincubation, unlike PGF and insulin.
  • PGF inhibited epinephrine-induced lipolysis, similar to insulin and hGH.
  • PGF did not displace 125I-insulin but competitively inhibited 125I-hGH binding.

Conclusions:

  • PGF possesses direct insulin-like actions mediated through growth hormone receptors.
  • PGF's insulin-like activity is independent of insulin receptors and is not affected by GH refractoriness.
  • PGF does not exhibit anti-insulin effects, distinguishing its metabolic profile.

Related Concept Videos